BoKDiff: Best-of-K Diffusion Alignment for Target-Specific 3D Molecule Generation
Ali Khodabandeh Yalabadi, Mehdi Yazdani-Jahromi, Ozlem Ozmen Garibay · 2025
Read BoKDiff: Best-of-K Diffusion Alignment for Target-Specific 3D Molecule Generation by Ali Khodabandeh Yalabadi, Mehdi Yazdani-Jahromi, Ozlem Ozmen Garibay (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2501-15631.txt.
Introduction
Ali Khodabandeh Yalabadi, Mehdi Yazdani-Jahromi, and Ozlem Ozmen Garibay present a 2025 method for designing drug-like molecules that fit a chosen protein target. Diffusion models can dream up new molecules in three dimensions, but good protein-ligand data is scarce and the dreamt shapes often sit askew in the target's pocket.
Their frame, BoKDiff, builds on an existing model and creates many candidates for each target. It ranks them with a blend of scores for drug-likeness, ease of making, and fit to the pocket. A recentering trick moves each candidate onto its best docked pose. Picking the best of many tries, with no retraining, gave strong scores and a success rate above a third on a standard test set.
Catalog record
| CREATOR | Ali Khodabandeh Yalabadi, Mehdi Yazdani-Jahromi, Ozlem Ozmen Garibay |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | http://creativecommons.org/licenses/by/4.0/ |
| RIGHTS | CC BY |
| SOURCE | arXiv |
Source: https://arxiv.org/abs/2501-15631
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
BoKDiff: Best-of-K Diffusion Alignment for Target-Specific 3D Molecule Generation Ali Khodabandeh Yalabadi, Mehdi Yazdani-Jahromi, Ozlem Ozmen Garibay Abstract Structure-based drug design (SBDD) leverages the 3D structure of biomolecular targets to guide the creation of new therapeutic agents. Recent advances in generative models, including diffusion models and geometric deep learning, have demonstrated promise in optimizing ligand generation. However, the scarcity of high-quality protein-ligand complex data and the inherent challenges in aligning generated ligands with target proteins limit the effectiveness of these methods. We propose BoKDiff, a novel framework that enhances ligand generation by combining multi-objective optimization and Best-of-K alignment methodologies. Built upon the DecompDiff model, BoKDiff generates diverse candidates and ranks them using a weighted evaluation of molecular properties such as QED, SA, and docking scores. To address alignment challenges, we introduce a method that relocates the center of mass of generated ligands to their docking poses, enabling accurate sub-component extraction. Additionally, we integrate a Best-of-N (BoN) sampling approach, which selects the optimal ligand from multiple generated candidates without requiring fine-tuning. BoN achieves exceptional results, with QED values exceeding 0.6, SA scores above 0.75, and a success rate surpassing 35%, demonstrating its efficiency and practicality. BoKDiff achieves state-of-the-art results on the CrossDocked2020 dataset, including a -8.58 average Vina docking score and a 26% success rate in molecule generation. This study is the first to apply Best-of-K alignment and Best-of-N sampling to SBDD, highlighting their potential to bridge generative modeling with practical drug discovery requirements. The code is provided at this GitHub URL . A.K. Yalabadi et al. \ast ]Corresponding author. [email protected] 0Year 0Year 0Year keywords 3D drug design, Best-of-N, Alignment, Diffusion models † † journal: Journal Title Here † † doi: DOI HERE † † copyright-year: 2022 † † year: 2019 † † access: Advance Access Publication Date: Day Month Year † † appnotes: Paper † † firstpage: 1 † † address: Department of Industrial Engineering and Management Systems, University of Central Florida, 4000 Central Florida Blvd, 32816, \state FL, USA † † address: Department of Computer Science, University of Central Florida, 4000 Central Florida Blvd, 32816, \state FL, USA † † corresponding: [ † † received: Date † † revised: Date † † accepted: Date 1 Introduction Structure-based drug design (SBDD) [ 1 ] leverages the 3D structures of biomolecules to facilitate the development and refinement of therapeutic agents. The primary aim is to design molecules that specifically interact with target proteins. Recent advancements have reframed this as a data-driven, conditional generative task, employing geometric deep learning to enhance molecular generation [ 19 ] . Strategies like SE(3)-equivariant auto-regressive models for sequentially generating atomic or fragment structures [ 18 , 28 ] and diffusion models for predicting atomic types and positions [ 16 , 10 ] have shown promise. Despite these innovations, the limited availability of high-quality protein-ligand complex data remains a key challenge [ 25 ] . Deep learning’s effectiveness often hinges on large-scale datasets, a luxury readily available in domains like computer vision and natural language processing due to accessible data sources. In contrast, generating protein-ligand binding data is inherently complex and resource-intensive. Datasets such as CrossDocked2020 [ 8 ] address this scarcity by augmenting data through docking ligands into diverse binding pockets. While this expands dataset size, it introduces potential compromises in data quality, as ligands may exhibit only moderate binding affinities, insufficient for rigorous drug design demands [ 30 ] . Additionally, this method fails to enhance the diversity of unique ligands, restricting generative models’ ability to learn from diverse molecular structures. To overcome these limitations, approaches like property-based molecule search [ 9 ] have explored vast chemical spaces for molecules with desirable traits. However, such methods lack the diversity and creativity of generative models. Conditional diffusion models integrated with iterative substructure optimization [ 30 ] have demonstrated improved molecular properties while preserving some diversity. Yet, these methods are constrained by static model parameters during optimization, which may limit their overall performance. The challenge of optimizing molecular properties remains significant. To address this, we propose BoKDiff, a multi-objective optimization framework that aligns and enhances existing diffusion models. Drawing inspiration from the effective RAFT (Reward rAnked FineTuning) alignment method [ 5 ] , our approach uses a Best-of-K methodology to curate high-reward subsets based on molecular properties. These curated subsets are then employed to fine-tune the diffusion models for generating ligands with improved molecular properties while maintaining or enhancing their docking performance. In addition, we explore the Best-of-N (BoN) sampling approach [ 12 ] as a complementary strategy for optimizing ligand generation. Unlike BoKDiff, BoN does not involve fine-tuning; instead, it directly selects the highest-reward ligand from N generated candidates based on a multi-objective reward function. This method offers improved molecular property results, such as QED over 0.6, SA above 0.75, and a success rate surpassing 35%. However, BoN’s computational cost is higher, making it less general and scalable compared to BoKDiff. Our study adopts the DecompDiff model [ 11 ] as the foundation, which generates candidate molecules by leveraging sub-pocket and sub-structure information, such as arms and scaffolds, from protein-ligand complexes. However, a key limitation of AI-generated ligands is their misalignment with target proteins, leading to failed sub-component extractions. To overcome this, we relocate the center of mass of generated ligands to align with the docking pose, ensuring proximity to the target protein. BoKDiff demonstrates superior performance, significantly outperforming baseline methods. Below, we summarize the key contributions of our work: • Our method surpasses the state-of-the-art DecompDiff model across multiple critical metrics, achieving a success rate increase from 24.5% to 26%, a QED improvement up to 13%, and Vina-related score enhancements up to 6%. These results highlight the effectiveness of our approach in generating higher-quality, more drug-like molecular candidates. • We introduce multi-objectivity to this domain and use three metrics, QED, SA, and Vina Docking Score (see 4.1.4 Evaluation section) to evaluate the generated samples and rank them based on a final reward value in a weighted sum manner. • We solve the proximity issue by relocating the selected best-of-K ligands to the center of mass of their docking poses, addressing alignment issues for sub-component extraction. • BoKDiff achieves a -8.58 average Vina Docking score and a 26% success rate for molecule generation on the CrossDocked2020 dataset. • We explored the Best-of-N (BoN) sampling approach, achieving superior QED, SA, and success rate values, and demonstrated its complementary potential to BoKDiff. • To the best of our knowledge, this is the first application of best-of-K alignment and BoN sampling to structure-based drug design, aligning generative models with the practical requirements of drug discovery. 2 Related works One significant area of focus in molecular design is the development of ligand molecules that can effectively bind to specific target proteins, commonly referred to as Structure-Based Drug Design (SBDD). In recent years, numerous efforts have been made to improve the process of generating molecules with desirable properties. For instance, Ragoza et al. [ 21 ] utilized variational autoencoders to produce 3D molecular structures represented as atomic density grids. Other approaches, such as those by Luo et al. [ 16 ] , Peng et al. [ 18 ] , and Liu et al. [ 15 ] , have employed autoregressive techniques